Together, our exploratory findings support the notion that CD163+ TAMs play a critical role in orchestrating lymphogenesis in VSCC by exhibiting enhanced VEGF-A expression and triggering increased VEGF-A levels in VSCC tumor cells. The gene discussed is CD163; the disease is neoplasm.